MCM2 and cancer: Consistent with our pan-cancer analysis findings that MCM2 is a potential biomarker for cancer diagnosis and prognosis, our results also indicated that MCM2 is an independent prognostic gene for SKCM, as assessed by a nomogram model according to baseline clinical data.